EDINA, Minn., Aug. 14 ARKRAY, Inc., today announced that its line of GLUCOCARD and Assure blood glucose meter test strips do not use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone), which the ...

MINNEAPOLIS, Dec. 8, 2025 /PRNewswire/ -- ARKRAY, a leader in clinical diagnostics and diabetes care solutions, proudly announces the launch of the Assure® Titanium Blood Glucose Monitoring System ...

MINNEAPOLIS Arkray USA on Tuesday introduced YouChoose, an exclusive patient wellness program that provides information on diabetes care and management. The free program is from Glucocard, Arkray’s ...

MINNEAPOLIS Arkray USA on Thursday announced 510(k) clearance from the Food and Drug Administration for its Glucocard 01-mini Blood Glucose Monitoring System. This new system requires no coding, ...

MINNEAPOLIS, Feb. 20, 2018 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes care products, announced today the Company was recognized at the recent Walmart Supplier Growth Summit as a finalist ...

MINNEAPOLIS, Aug. 4, 2017 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes care products, announced today the launch of the ARK Care ® Advance real-time diabetes management system and the ARK ...

MINNEAPOLIS, Aug. 26, 2019 /PRNewswire/ -- ARKRAY USA, Inc. announced today the US launch of Phazix, the first and only over-the-counter pill swallowing gel available in the US market. Phazix is all ...

Arkray USA, Inc, a leader in diabetes care products, has announced the US launch of the Glucocard Shine Connex Bluetooth enabled and the Glucocard Shine Express audio-enabled blood glucose monitoring ...

Japanese medical technology major ARKRAY Group is buying the In-Vitro Diagnostic (IVD) business of Gujarat-based Span Diagnostics Ltd (Span), as per a stock market disclosure. The equity value of the ...

ARKRAY USA has renamed its Long-term Care Division as the Professional Healthcare Division. The division will continue to provide medical devices to treat diabetes. These include Assure ® Platinum and ...

OSAKA -- Japanese medical equipment maker Arkray has developed a system that automates the culturing of insulin-producing pancreatic cells derived from induced pluripotent stem cells, or iPS cells.

Arkray launches Glucocard X-Meter monitor Arkray USA has launched the Glucocard X-Meter Blood Glucose Monitoring System for diabetics. Arkray USA has launched the Glucocard X-Meter Blood Glucose ...